Advertisement
Table 2 Predictors of long-term pancreatic complications for patients with documented pancreatic duct diameter after operation
| Variable | Long-term complication rate | Univariate p value | Multivariate p value | OR (95% CI) |
|---|---|---|---|---|
| Preoperative pancreatic duct diameter ≧ 3mm, n (%) | ||||
| No | 10/42 (23.8%) | 0.777 | ||
| Yes | 6/32 (18.8%) | |||
| Postoperative pancreatic duct diameter ≧ 3mm, n (%) | ||||
| No | 5/53 (9.4%) | < 0.001 | 0.002 | 19.0 (3.022-118.984) |
| Yes | 13/25 (52.0%) | |||
| Postoperative pancreatic parenchymal atrophy, n (%) | 0.001 | 21.2 (3.324-135.697) | ||
| No | 5/56 (8.9%) | < 0.001 | ||
| Yes | 13/22 (59.1%) | |||
| Pathology, n (%) | ||||
| Benign | 12/35 (34.3%) | 0.057 | 0.253 | 0.4 (0.067-2.038) |
| Malignant | 6/43 (14.0%) | |||
| Type of operation, n (%) | ||||
| Pancreaticoduodenectomy | 16/73 (21.9%) | 0.326 | ||
| Segment resection of pancreas | 2/5 (40.0%) | |||
| Pancreatic fistula, n (%) | ||||
| No | 15/61 (24.6%) | 0.748 | ||
| Yes | 3/17 (17.6%) | |||
| Adjuvant therapy, n (%) | ||||
| No | 13/59 (22.0%) | 0.002 | 0.087 | 9.3(0.725-118.506) |
| Chemotherapy | 0/12 (0.0%) | |||
| long-acting octreotide | 5/7 (71.4%) | |||
| I125 radioactive seeds implantation, n (%) | ||||
| No | 18/74 (24.3%) | 1.000 | ||
| Yes | 0/3 (0.0%) | |||
| Pancreatic duct stent retained > 2 years, n (%) | ||||
| No | 18/68 (26.5%) | 0.068 | ||
| Yes | 0/10 (0.0%) |
